Among them was David Liu, a biochemist at the Broad Institute and Harvard University in Cambridge, Massachusetts. Liu isn’t a ...

Researchers at Texas A&M are pairing a widely used ingredient with advanced medical technology to develop new treatments for ...

A new wellness business can be found at Rochester’s annual Social Ice events this weekend, offering mobile therapy services ...

Four couples who’ve made lasting impacts on charitable causes both here and across the nation have been named Grand Marshals ...

Novel, experimental treatment for emphysema may offer promising results for patients looking to breathe easier ...

Generate Biomedicines’ IPO aims to fund Phase 3 GB-0895 for severe asthma/COPD and expand its pipeline. Learn more about GENB ...

Stopping long-acting inhalers for chronic obstructive pulmonary disease (COPD) can lead to a sharp rise in flare-ups for ...

GSK plc GSK announced that the European Commission has approved its blockbuster respiratory drug, Nucala (mepolizumab), for ...

(Alliance News) - GSK PLC on Friday said the European Commission has approved Nucala, or mepolizumab, as add-on therapy for adults with chronic obstructive pulmonary disease.

Under Trump administration deals to lower drug prices, pharmaceutical companies are offering some of their drugs at ...

Sabari recommends regular activity, such as walking 30 minutes a day several times a week, to help maintain lung strength.

A new study led by the University of Miami Miller School of Medicine's Kirill Martemyanov, Ph.D., and international ...